GenON IPO November 2026: enterprise AI firm targets KOSDAQ
GenON, a Korean enterprise AI firm founded in 2017, booked KRW 11.76 billion in H1 2026 revenue, topping its full-year 2025 total of KRW 11.74 billion.
· 5 min read
Read in other languages한국어Español简体中文繁體中文日本語
Key takeaways (as of November 21, 2026)
- GenON plans to sell 2.2 million shares at KRW 9,700–12,200 each, raising up to KRW 26.8 billion in a KOSDAQ listing led by Samsung Securities.
- GenON's revenue in Q3 2026 was KRW 8.0 billion with an operating margin of 3.8%, down from 17.0% in the first half, making profitability the key question for the offering.

GenON's annual revenue was KRW 3.41 billion in 2023. This year it reached KRW 11.76 billion in the first half alone. GenON is a Korean company that builds generative AI for enterprises, and it is pursuing a regular listing on KOSDAQ, the market for technology and growth companies run by Korea Exchange, with Samsung Securities as lead manager. An amended registration statement filed on October 26 set retail subscription for November 24–25, but as of November 21 no final offer price had been announced, and the schedule may have shifted again. GenON is applying through the regular route on the strength of its profits, rather than the technology special listing track, which lets loss-making companies list on the basis of a technology assessment. That makes the offering a test of how the market values a Korean AI agent company.
What GenON builds: AI that runs inside the bank
GenON's core product is GenOS, an enterprise AI platform designed to handle the whole process on one platform, from AI adoption strategy to development, deployment and operation. Because it can run on air-gapped networks cut off from the internet, its main customers are financial institutions and public agencies. The company also sells OneAgent, an AI agent that carries out tasks directly, and GenA, a portal that brings multiple agents together. It supplies AI infrastructure such as GPUs as well, and in March this year it set up a research unit for physical AI. According to Newstop, Woori Bank and Korea Midland Power are among its customers.
"As an AI company that combines revenue growth with profitability, I believe these results are built on solid technology," CEO Ko Seok-tae said in an iNews24 report on September 22 announcing that GenON had passed the preliminary listing review. Ko is the largest shareholder, with a 44.57% stake.
From KRW 3.4 billion to KRW 11.7 billion, then a pause in Q3
| Period | Revenue (KRW bn) | Operating profit (KRW bn) |
|---|---|---|
| 2023 | 3.41 | -1.60 |
| 2024 | 8.63 | 1.02 |
| 2025 | 11.74 | 0.70 |
| H1 2026 | 11.76 | 2.00 (margin 17.0%) |
| Q3 2026 | 8.00 | 0.30 (margin 3.8%) |
The figures come from the registration statement as reported by the IPO data page of 38 Communication (checked November 21) and by Newstop (October 28); the Q3 figures are Newstop's. ZDNet Korea put first-half operating profit on a separate (non-consolidated) basis at KRW 2.2 billion, an 18.7% margin, so the numbers differ slightly depending on the basis used. Revenue for January–September totaled KRW 19.76 billion, and the order backlog not yet booked as revenue stood at KRW 20.07 billion. However, July and August were loss-making months, and the top three customers account for 45.3% of revenue. GenON still carries the profile of a systems integrator whose results swing on a handful of large projects.

The company's answer is licensing. Licenses made up 35.1% of first-half revenue, and GenON aims to lift that share above 40% next year. "Licenses carry almost no variable cost, so margins improve as their share grows," noted Kang Kyung-keun, an analyst at NH Investment & Securities.
What lies behind the KRW 9,700–12,200 price range
| Item | Details |
|---|---|
| Shares offered | 2.2 million |
| Indicative price range | KRW 9,700–12,200 |
| Offering size | KRW 21.34–26.84 billion |
| Market cap after listing | KRW 139.0–174.9 billion |
| P/E applied · discount | 40.96x · 11.74–29.83% |
| Lead manager | Samsung Securities |
Offering terms are as reported by ZDNet Korea (October 8) and Newstop (October 28). The price-to-earnings ratios of the comparable companies vary widely, from 18.29x to 54.52x. Wisenut and BI Matrix, listed companies grouped in the same sector, posted net losses in the first half. With profitable AI software companies still rare, the valuation GenON receives could become a benchmark for unlisted companies in the same field.
A listing window amid record venture investment
Money is flowing toward AI. Figures released on November 17 on Korea.kr, the government's policy news portal, by the Ministry of SMEs and Startups (MSS), which oversees small businesses and startups (formerly the Small and Medium Business Administration), show that new venture investment in Korea for January–September reached a record KRW 12.62 trillion, up 28.4% from a year earlier. By sector, ICT services drew the most, at KRW 2.5 trillion, and the ministry attributed the increase to large investments in AI-related fields. Strong investment appetite does not automatically mean a high offer price. The volume of shares that can be sold on the first trading day is another variable. Newstop reported on October 29 that shares held by financial investors who came in at KRW 3,000 per share were worth KRW 19.1 billion at the top of the price range. That is the value of shares eligible for sale, not the amount actually sold. Our November 14 article, "FuriosaAI raises KRW 820 billion: why investors backed a company with KRW 5.7 billion in revenue" (https://jemiboo.com/en/tech/2026-11-14/), looked at the heat in private investment; GenON shows that money being priced again on the public market. GenON amended its registration statement twice in October alone, and as of November 21, 38 Communication, a Korean IPO information site, lists a December schedule for book-building, the process in which institutional investors bid to set the offer price. Readers considering a subscription should check the final offer price and subscription dates in the latest amended statement on DART, the electronic disclosure system of the Financial Supervisory Service (FSS), Korea's financial regulator. This article summarizes recent developments and is not investment advice.
Frequently asked questions
What does GenON do?
GenON is a Korean enterprise generative AI company founded in 2017 that makes GenOS, an enterprise AI platform, and OneAgent, an AI agent. Because its systems can run on air-gapped networks, many of its customers are financial institutions and public agencies.
What is GenON's IPO price range and subscription date?
The indicative price range is KRW 9,700–12,200 per share for 2.2 million shares. An amended registration statement filed on October 26 set retail subscription for November 24–25, but as of November 21 no final offer price had been set and the schedule may have changed, so the latest amended filing on DART is the place to check.
Is GenON profitable?
GenON posted an operating profit in both 2024 and 2025, and its operating margin in the first half of 2026 was 17.0%, according to its registration statement. In the third quarter of 2026, however, the operating margin fell to 3.8%.
Sources
- ZDNet Korea, GenON launches KOSDAQ IPO offering, aiming to raise up to KRW 26.8 billion (October 8, 2026) — zdnet.co.kr
- Newstop, [IPO watch] GenON's margin falls from 17% to 3.8%: are expectations for a 'profitable AI' company wavering? (October 28, 2026) — newstopkorea.com
- Newstop, GenON: financial investors who came in at KRW 3,000 hold KRW 19.1 billion in shares sellable on listing day (October 29, 2026) — newstopkorea.com
- iNews24, GenON passes KOSDAQ preliminary listing review (September 22, 2026) — inews24.com
- Ministry of SMEs and Startups · Korea.kr, New venture investment and venture fund formation hit a record in Q1–Q3 (November 17, 2026) — korea.kr
- 38 Communication, GenON IPO information and financial summary (checked November 21, 2026) — 38.co.kr




